StockNews.AI
HUM
StockNews.AI
98 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM

1. Pomerantz LLP is investigating Humana for possible securities fraud. 2. The DOJ filed a complaint against Humana involving illegal kickbacks. 3. Humana's stock fell 2.36% on news of the DOJ lawsuit. 4. The lawsuit alleges misconduct spanning 2016 to 2021. 5. Investors are encouraged to contact Pomerantz LLP regarding potential claims.

3m saved
Insight
Article

FAQ

Why Bearish?

The ongoing DOJ investigation and lawsuit may significantly undermine investor confidence. Historical cases show similar circumstances lead to long-term stock declines.

How important is it?

The allegations could significantly affect Humana’s operational integrity and investor sentiment. As such, they warrant serious attention from current and prospective investors.

Why Long Term?

Legal battles often take years to resolve, impacting price stability and investor outlook. Previous lawsuits in the healthcare sector have triggered long-winded processes with lasting effects on stock prices.

Related Companies

UNHANTMCNC
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Humana and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On May 1, 2025, the U.S. Department of Justice (“DOJ”) announced the filing of a False Claims Act complaint against several health insurance companies and insurance broker organizations, including Humana, “alleg[ing] that from 2016 through at least 2021, the defendant insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments into the insurers’ Medicare Advantage plans.”  On news of the DOJ’s lawsuit, Humana’s stock price fell $6.20 per share, or 2.36%, to close at $256.04 per share on May 1, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: Danielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980 ext. 7980

Related News